193 related articles for article (PubMed ID: 33682610)
1. Acceptability and Effectiveness of Hepatitis C Care at Syringe Service Programs for People Who Inject Drugs in New York City.
Muncan B; Jordan AE; Perlman DC; Frank D; Ompad DC; Walters SM
Subst Use Misuse; 2021; 56(5):728-737. PubMed ID: 33682610
[No Abstract] [Full Text] [Related]
2. "They look at us like junkies": influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City.
Muncan B; Walters SM; Ezell J; Ompad DC
Harm Reduct J; 2020 Jul; 17(1):53. PubMed ID: 32736624
[TBL] [Abstract][Full Text] [Related]
3. HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England.
Romo E; Rudolph AE; Stopka TJ; Wang B; Jesdale BM; Friedmann PD
Addict Sci Clin Pract; 2023 Jan; 18(1):2. PubMed ID: 36597153
[TBL] [Abstract][Full Text] [Related]
4. Housing-based syringe services programs to improve access to safer injecting equipment for people who inject drugs in Vancouver, Canada: a spatially oriented qualitative study.
Chayama KL; Ng C; Fleming T; Small W; Sue KL; McNeil R
Harm Reduct J; 2023 Sep; 20(1):126. PubMed ID: 37679789
[TBL] [Abstract][Full Text] [Related]
5. The effects of COVID-19 on New York State's Drug User Health Hubs and syringe service programs: a qualitative study.
Ude M; Behrends CN; Kelly S; Schackman BR; Clear A; Goldberg R; Gelberg K; Kapadia SN
Harm Reduct J; 2023 Feb; 20(1):12. PubMed ID: 36732773
[TBL] [Abstract][Full Text] [Related]
6. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.
Allen ST; Grieb SM; O'Rourke A; Yoder R; Planchet E; White RH; Sherman SG
Harm Reduct J; 2019 May; 16(1):33. PubMed ID: 31109339
[TBL] [Abstract][Full Text] [Related]
7. Factors that influence enrollment in syringe services programs in rural areas: a qualitative study among program clients in Appalachian Kentucky.
Ibragimov U; Cooper KE; Batty E; Ballard AM; Fadanelli M; Gross SB; Klein EM; Lockard S; Young AM; Cooper HLF
Harm Reduct J; 2021 Jun; 18(1):68. PubMed ID: 34193165
[TBL] [Abstract][Full Text] [Related]
8. Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?
Grebely J; Dore GJ; Morin S; Rockstroh JK; Klein MB
J Int AIDS Soc; 2017 Jul; 20(1):22146. PubMed ID: 28782335
[TBL] [Abstract][Full Text] [Related]
9. Modeling Combination Hepatitis C Virus Treatment and Prevention Strategies in a Network of People Who Inject Drugs in the United States.
Zelenev A; Li J; Shea P; Hecht R; Altice FL
Clin Infect Dis; 2021 Mar; 72(5):755-763. PubMed ID: 32060534
[TBL] [Abstract][Full Text] [Related]
10. Were Needles Everywhere?: Differing Views on Syringe Waste and Disposal Associated With Needs-Based Syringe Services Programs Among Community Partners and Persons Who Inject Drugs.
Hershow RB; Love Pieczykolan L; Worthington N; Adams M; McDonald R; Wilson S; McBee S; Balleydier S; Curran KG
Subst Use Misuse; 2024; 59(8):1174-1181. PubMed ID: 38509704
[TBL] [Abstract][Full Text] [Related]
11. Access to HIV, Viral Hepatitis, and Substance Use Disorder Treatment/Overdose Prevention Services: A Qualitative Analysis of Syringe Service Programs (SSPs) Serving Rural PWID.
Carnes NA; Asher AK; Bohm MK; Bessler PA
Subst Use Misuse; 2021; 56(13):1933-1940. PubMed ID: 34353216
[TBL] [Abstract][Full Text] [Related]
12. Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and Rural Areas - United States, 2013.
Des Jarlais DC; Nugent A; Solberg A; Feelemyer J; Mermin J; Holtzman D
MMWR Morb Mortal Wkly Rep; 2015 Dec; 64(48):1337-41. PubMed ID: 26655918
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of scaling-up HCV prevention and treatment in the United States for people who inject drugs.
Barbosa C; Fraser H; Hoerger TJ; Leib A; Havens JR; Young A; Kral A; Page K; Evans J; Zibbell J; Hariri S; Vellozzi C; Nerlander L; Ward JW; Vickerman P
Addiction; 2019 Dec; 114(12):2267-2278. PubMed ID: 31307116
[TBL] [Abstract][Full Text] [Related]
14. Examining risk behavior and syringe coverage among people who inject drugs accessing a syringe services program: A latent class analysis.
Bartholomew TS; Tookes HE; Bullock C; Onugha J; Forrest DW; Feaster DJ
Int J Drug Policy; 2020 Apr; 78():102716. PubMed ID: 32146348
[TBL] [Abstract][Full Text] [Related]
15. 'Treat my whole person, not just my condition': qualitative explorations of hepatitis C care delivery preferences among people who inject drugs.
Tsui JI; Barry MP; Austin EJ; Sweek EW; Tung E; Hansen RN; Ninburg M; Scott JD; Glick SN; Williams EC
Addict Sci Clin Pract; 2021 Aug; 16(1):52. PubMed ID: 34384494
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of hepatitis C virus (HCV) elimination strategies among people who inject drugs (PWID) in Tijuana, Mexico.
Marquez LK; Fleiz C; Burgos JL; Cepeda JA; McIntosh C; Garfein RS; Kiene SM; Brodine S; Strathdee SA; Martin NK
Addiction; 2021 Oct; 116(10):2734-2745. PubMed ID: 33620750
[TBL] [Abstract][Full Text] [Related]
17. M
Martel-Laferrière V; Feaster DJ; Metsch LR; Schackman BR; Loignon C; Nosyk B; Tookes H; Behrends CN; Arruda N; Adigun O; Goyer ME; Kolber MA; Mary JF; Rodriguez AE; Yanez IG; Pan Y; Khemiri R; Gooden L; Sako A; Bruneau J
Trials; 2022 Apr; 23(1):341. PubMed ID: 35461260
[TBL] [Abstract][Full Text] [Related]
18. Pre-Exposure Prophylaxis Barriers, Facilitators and Unmet Need Among Rural People Who Inject Drugs: A Qualitative Examination of Syringe Service Program Client Perspectives.
Surratt HL; Yeager HJ; Adu A; González EA; Nelson EO; Walker T
Front Psychiatry; 2022; 13():905314. PubMed ID: 35706473
[TBL] [Abstract][Full Text] [Related]
19. Scaling-up HCV prevention and treatment interventions in rural United States-model projections for tackling an increasing epidemic.
Fraser H; Zibbell J; Hoerger T; Hariri S; Vellozzi C; Martin NK; Kral AH; Hickman M; Ward JW; Vickerman P
Addiction; 2018 Jan; 113(1):173-182. PubMed ID: 28734093
[TBL] [Abstract][Full Text] [Related]
20. Barriers and facilitators of HIV and hepatitis C care among people who inject drugs in Nairobi, Kenya: a qualitative study with peer educators.
Ludwig-Barron NT; Guthrie BL; Mbogo L; Bukusi D; Sinkele W; Gitau E; Farquhar C; Monroe-Wise A
Harm Reduct J; 2021 Dec; 18(1):133. PubMed ID: 34922548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
